- Home
- VERB vs KZIA Comparison
VERB vs KZIA Comparison
Compare VERB & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERB
- KZIA
- Stock Information
- Founded
- VERB 2014
- KZIA 1994
- Country
- VERB United States
- KZIA Australia
- Employees
- VERB N/A
- KZIA N/A
- Industry
- VERB Other Consumer Services
- KZIA Biotechnology: Pharmaceutical Preparations
- Sector
- VERB Consumer Discretionary
- KZIA Health Care
- Exchange
- VERB Nasdaq
- KZIA Nasdaq
- Market Cap
- VERB 5.8M
- KZIA 5.1M
- IPO Year
- VERB N/A
- KZIA 1999
- Fundamental
- Price
- VERB $8.98
- KZIA $5.65
- Analyst Decision
- VERB Strong Buy
- KZIA Strong Buy
- Analyst Count
- VERB 1
- KZIA 2
- Target Price
- VERB $62.00
- KZIA $57.50
- AVG Volume (30 Days)
- VERB 111.1K
- KZIA 24.0K
- Earning Date
- VERB 05-13-2025
- KZIA 06-17-2025
- Dividend Yield
- VERB N/A
- KZIA N/A
- EPS Growth
- VERB N/A
- KZIA N/A
- EPS
- VERB N/A
- KZIA N/A
- Revenue
- VERB $2,193,000.00
- KZIA $1,655,324.00
- Revenue This Year
- VERB $287.49
- KZIA N/A
- Revenue Next Year
- VERB $47.06
- KZIA N/A
- P/E Ratio
- VERB N/A
- KZIA N/A
- Revenue Growth
- VERB 3125.00
- KZIA 248000.00
- 52 Week Low
- VERB $3.81
- KZIA $2.86
- 52 Week High
- VERB $30.98
- KZIA $79.00
- Technical
- Relative Strength Index (RSI)
- VERB 73.50
- KZIA 78.10
- Support Level
- VERB $5.94
- KZIA $3.54
- Resistance Level
- VERB $8.49
- KZIA $4.00
- Average True Range (ATR)
- VERB 0.67
- KZIA 0.50
- MACD
- VERB 0.23
- KZIA 0.25
- Stochastic Oscillator
- VERB 83.31
- KZIA 86.07
About VERB Verb Technology Company Inc.
Verb Technology Co Inc leader in interactive video-based sales applications, transforms how businesses attract and engage customers. VERB's Software-as-a-Service platform, based on its proprietary interactive video technology, comprises a suite of easy-to-use, subscription-based sales enablement software products. The segments of the company are MARKET.live and Go Fund Yourself, and it derives maximum revenue from MARKET.live segment.
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.